The Evolving Landscape of Immunotherapy in Solid Cancers

This panel will discuss the evolving landscape of immunotherapy in solid tumors, in particular with a focus on clinical-stage studies in development. The speakers will provide a diverse range of new emerging modalities in cancer drug development, from programmable mRNA, to oncolytic immunotherapy and targeted small molecule drugs in development. The panel will specifically discuss the latest clinical developments in new therapies to treat solid cancers, and upcoming emerging trends.